HPV Vaccine

ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP)
Promoting Openness, Full Disclosure, and Accountability
http://www.ahrp.org and http://ahrp.blogspot.com

We are gratified that Texas Governor Rick Perry's Executive Order mandating
HPV Vaccine Carries NO Force of Law! It's dead on arrival.

The order, issued on Friday before Super Bowl, mandating all six grade girls
to be vaccinated with Merck's HPV vaccine, Gardasil, is rescinded.
Critics--including AHRP--recognized that "Perry's end run around the news
cycle and the Legislature is less about women's health than it is about
lobby dollars and commissions."

Indeed, Fox News reported that Merck doubled its spending on lobbyists in
Texas this year, to between $150,000 and $250,000, as lawmakers consider the
vaccine bill for girls entering the sixth grade.
http://www.foxnews.com/story/0,2933,248781,00.html

For Merck, this was an investment worth making. inasmuch as the vaccine is
projected to bring in over a billion dollars annually--multi-billions if
mandatory. Gardasil does NOT prevent all sexually transmitted cancer or
other sexually transmitted diseases. It may potentially lead to INCREASED
cervical cancer if vaccinated women think they are protected and fail to
have PAP smear tests.

Merck's aggressive marketing of Gardasil is a cynical effort to shift the
company's financial burden from its Vioxx lititgation to taxpayers.
Merck's marketing strategy for the HPV vaccine was intended to "Help Pay for
Vioxx."

The publi



Russell B.Olinsky, M.S.
Environmental Specialist

JOHN wrote:

ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP)
Promoting Openness, Full Disclosure, and Accountability
http://www.ahrp.org and http://ahrp.blogspot.com

We are gratified that Texas Governor Rick Perry's Executive Order mandating
HPV Vaccine Carries NO Force of Law! It's dead on arrival.

It never had, but that didn't stop the anti-vaccination liars from
screaming bloody murder.

The order, issued on Friday before Super Bowl, mandating all six grade girls
to be vaccinated with Merck's HPV vaccine, Gardasil, is rescinded.
Critics--including AHRP--recognized that "Perry's end run around the news
cycle and the Legislature is less about women's health than it is about
lobby dollars and commissions."

Indeed, Fox News reported that Merck doubled its spending on lobbyists in
Texas this year, to between $150,000 and $250,000, as lawmakers consider the
vaccine bill for girls entering the sixth grade.
http://www.foxnews.com/story/0,2933,248781,00.html

Do these people have any clue what lobbying costs? $250,000 a year is
barely enough for the office space.

For Merck, this was an investment worth making. inasmuch as the vaccine is
projected to bring in over a billion dollars annually--multi-billions if
mandatory. Gardasil does NOT prevent all sexually transmitted cancer or
other sexually transmitted diseases.

So Mr. Olinsky admits that it at minimum protects agains SOME sexually
transmitted cancer. As for the 'other sexually transmitted diseases' -
when did Merck or anyone ever claimed it did? It's the *HPV* vaccine, it
targets HPV and to the best of my knowledge, there is no claim anywhere
it does anything more. I think my stock in 'Fallacy Inc', makers of the
world's finest straw men, has just gone up.

It may potentially lead to INCREASED cervical cancer if vaccinated women
think they are protected and fail to have PAP smear tests.

Which has nothing to do with the vaccine itself. Apparently, Mr. Olinsky
can find no fault with the vaccine itself, so he has to resort to this.
Sad. But at least he implicitely admits the vaccine itself is totally safe.

Merck's aggressive marketing of Gardasil is a cynical effort to shift the
company's financial burden from its Vioxx lititgation to taxpayers.

Wouldn't Merck make more money on treating women who get cervical cancer
in stead of preventing it? Compare to profit of one shot per lifetime of
about $ 350.- to months, maybe even years of treatment. Methinks Mr.
Olinksy hasn't quite thought things through.

Merck's marketing strategy for the HPV vaccine was intended to "Help Pay for
Vioxx."

Yeah, sure. Now finally there is a working vaccine against a very nasty
form of cancer, and all John Scumamore, the anti-vaccination liars and
apparently Mr. Olinsky can do is complain.

The publi


Russell B.Olinsky, M.S.
Environmental Specialist

I guess that means he sweeps the streets somewhere.

"JohnDoe" wrote in message
.. .
JOHN wrote:

ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP)
Promoting Openness, Full Disclosure, and Accountability
http://www.ahrp.org and http://ahrp.blogspot.com

We are gratified that Texas Governor Rick Perry's Executive Order
mandating
HPV Vaccine Carries NO Force of Law! It's dead on arrival.

It never had, but that didn't stop the anti-vaccination liars from
screaming bloody murder.

The order, issued on Friday before Super Bowl, mandating all six grade
girls
to be vaccinated with Merck's HPV vaccine, Gardasil, is rescinded.
Critics--including AHRP--recognized that "Perry's end run around the news
cycle and the Legislature is less about women's health than it is about
lobby dollars and commissions."

Indeed, Fox News reported that Merck doubled its spending on lobbyists in
Texas this year, to between $150,000 and $250,000, as lawmakers consider
the
vaccine bill for girls entering the sixth grade.
http://www.foxnews.com/story/0,2933,248781,00.html

Do these people have any clue what lobbying costs? $250,000 a year is
barely enough for the office space.

For Merck, this was an investment worth making. inasmuch as the vaccine
is
projected to bring in over a billion dollars annually--multi-billions if
mandatory. Gardasil does NOT prevent all sexually transmitted cancer or
other sexually transmitted diseases.

So Mr. Olinsky admits that it at minimum protects agains SOME sexually
transmitted cancer. As for the 'other sexually transmitted diseases' -
when did Merck or anyone ever claimed it did? It's the *HPV* vaccine, it
targets HPV and to the best of my knowledge, there is no claim anywhere it
does anything more. I think my stock in 'Fallacy Inc', makers of the
world's finest straw men, has just gone up.

It may potentially lead to INCREASED cervical cancer if vaccinated women
think they are protected and fail to have PAP smear tests.

Which has nothing to do with the vaccine itself. Apparently, Mr. Olinsky
can find no fault with the vaccine itself, so he has to resort to this.
Sad. But at least he implicitely admits the vaccine itself is totally
safe.

Merck's aggressive marketing of Gardasil is a cynical effort to shift the
company's financial burden from its Vioxx lititgation to taxpayers.

Wouldn't Merck make more money on treating women who get cervical cancer
in stead of preventing it? Compare to profit of one shot per lifetime of
about $ 350.- to months, maybe even years of treatment. Methinks Mr.
Olinksy hasn't quite thought things through.

Merck's marketing strategy for the HPV vaccine was intended to "Help Pay
for
Vioxx."

Yeah, sure. Now finally there is a working vaccine against a very nasty
form of cancer, and all John Scumamore, the anti-vaccination liars and
apparently Mr. Olinsky can do is complain.

The publi


Russell B.Olinsky, M.S.
Environmental Specialist

JohnDoe, IDIOT!

t wrote:

"JohnDoe" wrote in message
.. .

JOHN wrote:


ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP)
Promoting Openness, Full Disclosure, and Accountability
http://www.ahrp.org and http://ahrp.blogspot.com

We are gratified that Texas Governor Rick Perry's Executive Order
mandating
HPV Vaccine Carries NO Force of Law! It's dead on arrival.

It never had, but that didn't stop the anti-vaccination liars from
screaming bloody murder.


The order, issued on Friday before Super Bowl, mandating all six grade
girls
to be vaccinated with Merck's HPV vaccine, Gardasil, is rescinded.
Critics--including AHRP--recognized that "Perry's end run around the news
cycle and the Legislature is less about women's health than it is about
lobby dollars and commissions."

Indeed, Fox News reported that Merck doubled its spending on lobbyists in
Texas this year, to between $150,000 and $250,000, as lawmakers consider
the
vaccine bill for girls entering the sixth grade.
http://www.foxnews.com/story/0,2933,248781,00.html

Do these people have any clue what lobbying costs? $250,000 a year is
barely enough for the office space.


For Merck, this was an investment worth making. inasmuch as the vaccine
is
projected to bring in over a billion dollars annually--multi-billions if
mandatory. Gardasil does NOT prevent all sexually transmitted cancer or
other sexually transmitted diseases.

So Mr. Olinsky admits that it at minimum protects agains SOME sexually
transmitted cancer. As for the 'other sexually transmitted diseases' -
when did Merck or anyone ever claimed it did? It's the *HPV* vaccine, it
targets HPV and to the best of my knowledge, there is no claim anywhere it
does anything more. I think my stock in 'Fallacy Inc', makers of the
world's finest straw men, has just gone up.


It may potentially lead to INCREASED cervical cancer if vaccinated women
think they are protected and fail to have PAP smear tests.

Which has nothing to do with the vaccine itself. Apparently, Mr. Olinsky
can find no fault with the vaccine itself, so he has to resort to this.
Sad. But at least he implicitely admits the vaccine itself is totally
safe.


Merck's aggressive marketing of Gardasil is a cynical effort to shift the
company's financial burden from its Vioxx lititgation to taxpayers.

Wouldn't Merck make more money on treating women who get cervical cancer
in stead of preventing it? Compare to profit of one shot per lifetime of
about $ 350.- to months, maybe even years of treatment. Methinks Mr.
Olinksy hasn't quite thought things through.


Merck's marketing strategy for the HPV vaccine was intended to "Help Pay
for
Vioxx."

Yeah, sure. Now finally there is a working vaccine against a very nasty
form of cancer, and all John Scumamore, the anti-vaccination liars and
apparently Mr. Olinsky can do is complain.


The publi


Russell B.Olinsky, M.S.
Environmental Specialist


JohnDoe, IDIOT!

Tools! You didn´t toppost! Oh, I am so proud of you! You have made my day.

Oh, I'm sorry, I will do better.
"JohnDoe" wrote in message
...
t wrote:

"JohnDoe" wrote in message
.. .

JOHN wrote:


ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP)
Promoting Openness, Full Disclosure, and Accountability
http://www.ahrp.org and http://ahrp.blogspot.com

We are gratified that Texas Governor Rick Perry's Executive Order
mandating
HPV Vaccine Carries NO Force of Law! It's dead on arrival.

It never had, but that didn't stop the anti-vaccination liars from
screaming bloody murder.


The order, issued on Friday before Super Bowl, mandating all six grade
girls
to be vaccinated with Merck's HPV vaccine, Gardasil, is rescinded.
Critics--including AHRP--recognized that "Perry's end run around the
news
cycle and the Legislature is less about women's health than it is about
lobby dollars and commissions."

Indeed, Fox News reported that Merck doubled its spending on lobbyists
in
Texas this year, to between $150,000 and $250,000, as lawmakers consider
the
vaccine bill for girls entering the sixth grade.
http://www.foxnews.com/story/0,2933,248781,00.html

Do these people have any clue what lobbying costs? $250,000 a year is
barely enough for the office space.


For Merck, this was an investment worth making. inasmuch as the vaccine
is
projected to bring in over a billion dollars annually--multi-billions if
mandatory. Gardasil does NOT prevent all sexually transmitted cancer or
other sexually transmitted diseases.

So Mr. Olinsky admits that it at minimum protects agains SOME sexually
transmitted cancer. As for the 'other sexually transmitted diseases' -
when did Merck or anyone ever claimed it did? It's the *HPV* vaccine, it
targets HPV and to the best of my knowledge, there is no claim anywhere
it does anything more. I think my stock in 'Fallacy Inc', makers of the
world's finest straw men, has just gone up.


It may potentially lead to INCREASED cervical cancer if vaccinated women
think they are protected and fail to have PAP smear tests.

Which has nothing to do with the vaccine itself. Apparently, Mr. Olinsky
can find no fault with the vaccine itself, so he has to resort to this.
Sad. But at least he implicitely admits the vaccine itself is totally
safe.


Merck's aggressive marketing of Gardasil is a cynical effort to shift
the
company's financial burden from its Vioxx lititgation to taxpayers.

Wouldn't Merck make more money on treating women who get cervical cancer
in stead of preventing it? Compare to profit of one shot per lifetime of
about $ 350.- to months, maybe even years of treatment. Methinks Mr.
Olinksy hasn't quite thought things through.


Merck's marketing strategy for the HPV vaccine was intended to "Help Pay
for
Vioxx."

Yeah, sure. Now finally there is a working vaccine against a very nasty
form of cancer, and all John Scumamore, the anti-vaccination liars and
apparently Mr. Olinsky can do is complain.


The publi


Russell B.Olinsky, M.S.
Environmental Specialist


JohnDoe, IDIOT!

Tools! You didn´t toppost! Oh, I am so proud of you! You have made my day.

Vaccine Safety Group Releases GARDASIL Reaction Report


Calls on FDA and CDC to Warn Doctors and Parents to Report to VAERS

WASHINGTON, Feb. 21 /PRNewswire-USNewswire/ -- The National Vaccine
Information Center (NVIC) today released a new analysis of the federal
Vaccine Adverse Event Reporting System (VAERS) reports of serious health
problems following HPV vaccination (Merck's GARDASIL) during the last six
months of 2006. Out of the 385 individual GARDASIL adverse event reports
made to VAERS, two-thirds required additional medical care and about
one-third of all reports were for children 16-years-old and under, with
nearly 25 percent of those children having received simultaneously one or
more of the 18 vaccines that Merck did not study in combination with
GARDASIL. NVIC is calling on the FDA and CDC to warn parents and doctors
that GARDASIL should not be combined with other vaccines and that young
girls should be monitored for at least 24 hours for syncopal
(collapse/fainting) episodes that can be accompanied by seizure activity, as
well as symptoms of tingling, numbness and loss of sensation in the
fingers and limbs, all of which should be reported to VAERS immediately.
"Because Merck only studied GARDASIL in fewer than 1200 girls under age
16 in pre-licensure trials, it is critical that doctors and parents be made
aware of the nature of the initial adverse event reports coming into VAERS
and that they report serious health problems after vaccination when they
occur," said NVIC President Barbara Loe Fisher. "There are twice as many
children collapsing and four times as many children experiencing tingling,
numbness and loss of sensation after getting a GARDASIL vaccination compared
to those getting a Tdap (tetanus-diphtheria-acellular pertussis)
vaccination. There have been reports of facial paralysis and Guillain-Barre
Syndrome. And doctors who give GARDASIL in combination with other vaccines
are basically conducting an experiment on their young patients because Merck
has not published any safety data for simultaneous vaccination with
any vaccine except hepatitis B vaccine."
According to NVIC's report, a majority of GARDASIL adverse event reports
to VAERS involved those who suffered fever, nausea, headache or
pain; 14 percent were for syncopal episodes with or without neurological
signs; and 8 percent experienced tingling, numbness and loss of sensation,
facial paralysis or Guillain-Barre Syndrome. Although adverse event reports
to VAERS do not prove causation, they can provide an early warning sign
that a new vaccine may be causing health problems that could be important.
For example, reports to VAERS of bowel blockage (intussusception) in babies
following receipt of Merck's Rota Teq (rotavirus) vaccine prompted the FDA
to issue a public warning to doctors and consumers on Feb. 13.

"About 4 reports per day were filed with VAERS in December 2006 for the
HPV vaccine," said NVIC Health Policy Analyst Vicky Debold, RN, Ph.D. "Some
of these girls are being injured when they collapse after getting the
vaccine and others are complaining of neurological symptoms that should not
be ignored. Doctors and nurses should take note of the patient safety issues
related to giving this vaccine. Giving GARDASIL simultaneously with
any of the 18 vaccines Merck did not study in combination is not an
evidence-based guideline and should involve informed consent and a signed
patient release. To avoid unnecessary injuries, teenage girls should be
vaccinated laying down, not be left unattended and probably should not walk
or drive themselves home from the doctor's office after they get
vaccinated."
NVIC also found that there were several VAERS reports of HPV infection,
genital warts and cervical lesions after GARDASIL vaccination. It is
unknown if the girls were infected with HPV before being vaccinated or if
GARDASIL failed to protect them. One case of HPV infection occurred in a
22-year-old girl who had participated in a Merck GARDASIL trial in 2003 when
she had shown "strong conversion to all 4 vaccine types" but "tested
positive for high risk HPV" in 2006, according to the VAERS report.
In a May 18, 2006 Background Document for the FDA Vaccines and Related
Biological Products Advisory Committee (VRPBAC), the FDA staff stated that
Merck clinical trial data indicated there may be "the potential for GARDASIL
to enhance cervical disease in subjects who had evidence of persistent
infection with vaccine-relevant HPV types prior to vaccination."
Girls and women now being vaccinated with GARDASIL are not routinely being
tested for active HPV infection before vaccination.

The FDA staff also questioned whether the "HPV types not contained in
the vaccine might offset the overall clinical effectiveness of the
vaccine." There are more than 15 types of HPV associated with cervical
cancer but GARDASIL only contains HPV types 16 and 18. It is unknown
whether non-vaccine HPV types will become more dominant in the future.
However, there are indications this could occur because some of the seven
strains of pneumococcal contained in Wyeth's PREVNAR vaccine, which was
recommended by the CDC for universal use in all babies in 2000, have been
replaced by some of the more than 80 other pneumococcal strains not
contained in the vaccine.
VAERS is a passive surveillance system and depends upon voluntary
reporting of serious health problems following vaccination, even though
safety provisions in the National Childhood Vaccine Injury Act of 1986
mandated that health care providers report vaccine adverse events. There
have been estimates that fewer than 10 percent, even as low as 1 to 4
percent, of adverse events which occur after prescription drug or vaccine
use are ever reported to government adverse event reporting systems.
"If only 1 to 4 percent of all adverse events associated with GARDASIL
vaccination are being reported to VAERS, there could have been up to 38,000
health problems after GARDASIL vaccination in 2006 which were never
reported," said Fisher. "How many girls are really having short-term health
problems associated with getting this vaccine that could turn into long-term
neurological or immune system disorders? And how many will go on
to develop fertility problems, cancer or damage to their genes, all of which
Merck admits in its product insert that it has not studied at all? We
just don't know enough to be mandating GARDASIL for anyone, much less
vulnerable 11 to 12 year old girls entering puberty."
For a copy of NVIC's Report on VAERS and GARDASIL, references for this
statement and information about how to report a vaccine reaction to VAERS,
go to http://www.nvic.org.

"JOHN" wrote in message
...
Vaccine Safety Group Releases GARDASIL Reaction Report


Calls on FDA and CDC to Warn Doctors and Parents to Report to VAERS

WASHINGTON, Feb. 21 /PRNewswire-USNewswire/ -- The National Vaccine
Information Center (NVIC) today released a new analysis of the federal

This shouldbe called the National Vaccine Misinformation Center

Vaccine Adverse Event Reporting System (VAERS) reports of serious health
problems following HPV vaccination (Merck's GARDASIL) during the last six
months of 2006. Out of the 385 individual GARDASIL adverse event reports
made to VAERS, two-thirds required additional medical care and about
one-third of all reports were for children 16-years-old and under, with
nearly 25 percent of those children having received simultaneously one or
more of the 18 vaccines that Merck did not study in combination with
GARDASIL. NVIC is calling on the FDA and CDC to warn parents and doctors
that GARDASIL should not be combined with other vaccines and that young
girls should be monitored for at least 24 hours for syncopal
(collapse/fainting) episodes that can be accompanied by seizure activity,
as well as symptoms of tingling, numbness and loss of sensation in the
fingers and limbs, all of which should be reported to VAERS immediately.


That's true of an event that *might* be related to the vaccine.

"Because Merck only studied GARDASIL in fewer than 1200 girls under age
16 in pre-licensure trials, it is critical that doctors and parents be
made
aware of the nature of the initial adverse event reports coming into VAERS
and that they report serious health problems after vaccination when they
occur," said NVIC President Barbara Loe Fisher. "There are twice as many
children collapsing and four times as many children experiencing tingling,
numbness and loss of sensation after getting a GARDASIL vaccination
compared to those getting a Tdap (tetanus-diphtheria-acellular pertussis)
vaccination. There have been reports of facial paralysis and
Guillain-Barre Syndrome. And doctors who give GARDASIL in combination with
other vaccines
are basically conducting an experiment on their young patients because
Merck has not published any safety data for simultaneous vaccination with
any vaccine except hepatitis B vaccine."
According to NVIC's report, a majority of GARDASIL adverse event
reports to VAERS involved those who suffered fever, nausea, headache or
pain; 14 percent were for syncopal episodes with or without neurological
signs; and 8 percent experienced tingling, numbness and loss of sensation,
facial paralysis or Guillain-Barre Syndrome. Although adverse event
reports to VAERS do not prove causation, they can provide an early warning
sign
that a new vaccine may be causing health problems that could be important.
For example, reports to VAERS of bowel blockage (intussusception) in
babies
following receipt of Merck's Rota Teq (rotavirus) vaccine prompted the FDA
to issue a public warning to doctors and consumers on Feb. 13.

Actually, the number of cases of intussusception was within the expected
range. The FDA was basically reporting a non-event.

"About 4 reports per day were filed with VAERS in December 2006 for the
HPV vaccine," said NVIC Health Policy Analyst Vicky Debold, RN, Ph.D.
"Some
of these girls are being injured when they collapse after getting the
vaccine and others are complaining of neurological symptoms that should
not
be ignored. Doctors and nurses should take note of the patient safety
issues related to giving this vaccine. Giving GARDASIL simultaneously with
any of the 18 vaccines Merck did not study in combination is not an
evidence-based guideline and should involve informed consent and a signed
patient release. To avoid unnecessary injuries, teenage girls should be
vaccinated laying down, not be left unattended and probably should not
walk
or drive themselves home from the doctor's office after they get
vaccinated."

Especially if they are too young to drive.

NVIC also found that there were several VAERS reports of HPV infection,
genital warts and cervical lesions after GARDASIL vaccination.

The HPV vaccine is not applied to the area where the leasions were. It is
unlikely that it was the cause of the lesions.

It is
unknown if the girls were infected with HPV before being vaccinated or if
GARDASIL failed to protect them. One case of HPV infection occurred in a
22-year-old girl who had participated in a Merck GARDASIL trial in 2003
when she had shown "strong conversion to all 4 vaccine types" but "tested
positive for high risk HPV" in 2006, according to the VAERS report.
In a May 18, 2006 Background Document for the FDA Vaccines and Related
Biological Products Advisory Committee (VRPBAC), the FDA staff stated that
Merck clinical trial data indicated there may be "the potential for
GARDASIL to enhance cervical disease in subjects who had evidence of
persistent infection with vaccine-relevant HPV types prior to
vaccination."
Girls and women now being vaccinated with GARDASIL are not routinely being
tested for active HPV infection before vaccination.

That is because there is no evidence that the vaccine does any harm in
peopel already exposed to the virus.

The FDA staff also questioned whether the "HPV types not contained in
the vaccine might offset the overall clinical effectiveness of the
vaccine." There are more than 15 types of HPV associated with cervical
cancer but GARDASIL only contains HPV types 16 and 18. It is unknown
whether non-vaccine HPV types will become more dominant in the future.
However, there are indications this could occur because some of the seven
strains of pneumococcal contained in Wyeth's PREVNAR vaccine, which was
recommended by the CDC for universal use in all babies in 2000, have been
replaced by some of the more than 80 other pneumococcal strains not
contained in the vaccine.

Actually, no bacteria are contained in the vaccine. They use preservatives
to prevent that.

VAERS is a passive surveillance system and depends upon voluntary
reporting of serious health problems following vaccination, even though
safety provisions in the National Childhood Vaccine Injury Act of 1986
mandated that health care providers report vaccine adverse events. There
have been estimates that fewer than 10 percent, even as low as 1 to 4
percent, of adverse events which occur after prescription drug or vaccine
use are ever reported to government adverse event reporting systems.
"If only 1 to 4 percent of all adverse events associated with GARDASIL
vaccination are being reported to VAERS, there could have been up to
38,000
health problems after GARDASIL vaccination in 2006 which were never
reported," said Fisher. "How many girls are really having short-term
health
problems associated with getting this vaccine that could turn into
long-term neurological or immune system disorders? And how many will go on
to develop fertility problems, cancer or damage to their genes, all of
which Merck admits in its product insert that it has not studied at all?
We
just don't know enough to be mandating GARDASIL for anyone, much less
vulnerable 11 to 12 year old girls entering puberty."

Yeah, lets just watch some of these girls die during what should be their
best years of their lives from cervical cancer.

For a copy of NVIC's Report on VAERS and GARDASIL, references for this
statement and information about how to report a vaccine reaction to VAERS,
go to http://www.nvic.org.

"Jeff" wrote in message
news:NP3Dh.3360$vu2.1432@trnddc04...


This shouldbe called the National Vaccine Misinformation Center

you should know http://www.whale.to/m/map.html


Pharma drivel deleted

"JOHN" wrote in message
...

"Jeff" wrote in message
news:NP3Dh.3360$vu2.1432@trnddc04...


This shouldbe called the National Vaccine Misinformation Center

you should know http://www.whale.to/m/map.html


Pharma drivel deleted

You lied by making it look like I said something I didn't.

And you call me a Putz?

I won't tell you what this makes you, because such lanquage is not fit for
this forum.

Jeff